In 2010, biotech venture capital investing recovered from its 2009 low, growing three percent in dollars and eight percent in deals. That represents a significant bounce-back from 2009. That’s according to a MoneyTree Report by PricewaterhouseCoopers and the National Venture Capital Association, based on data from Thomson Reuters.
Read the full article at the FierceBiotech website.
Tell Us About Your Multifaceted Career We see an increasing number of doctors deciding not to ... PRN Notable Quote Here is today's notable quote from Physician Renaissance Network. When ... Michael Crichton, MD After graduating from the Harvard Medical School, Michael Crichton embarked ... Tess Gerritsen, MD Tess Gerritsen took an unusual route to a writing career. A ...Copyright © 2004-2024 Physician Renaissance Network. All Rights Reserved.
